Trial Profile
Randomized phase II study of sorafenib and hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Nov 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Cisplatin
- Indications Liver cancer
- Focus Therapeutic Use
- 01 Nov 2016 Results (n=108) published in the Annals of Oncology.
- 29 Jul 2015 Status changed from recruiting to completed, as reported by University Hospital Medical Information Network- Japan record (UMIN000005703)
- 03 Jun 2011 New trial record